Analysts Viewpoint
Sharp decrease in CRNX’s short interest leads to decline in days-to-cover ratio
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Crinetics Pharmaceuticals Inc’s recently made public that its Chief Scientific Officer Betz Stephen F. unloaded Company’s shares for reported $3.14